Furthermore, our knowledge of HCC-specific epigenomic signatures and its effect on the methylation pattern of PPARγ, when coexisting with NAFLD, should be assessed in future studies. The gene discussed is PPARG; the disease is metabolic dysfunction-associated steatotic liver disease.